In a recent interview with the Financial Times, Sriram Krishnan, the White House's outgoing adviser on artificial intelligence, clarified that there will be no formal licensing requirements for AI technologies under the Trump administration.
Krishnan emphasized that the administration does not plan to create an equivalent of the FDA specifically for AI, which has been a topic of discussion among policymakers and industry leaders.
This announcement reflects the administration's stance on fostering innovation in the AI sector without imposing stringent regulatory frameworks.